More NewsRead More
Achillion to Present at Two Upcoming Investor Conferences
March 03, 2016
Achillion Reports 2015 Fourth Quarter and Year-End Financial Results
February 25, 2016
Achillion Initiates Phase 1 Study of ACH-4471, First Orally-Administered Small Molecule Complement Factor D Inhibitor
February 11, 2016
Early Briefing on Biotechnology Stocks -- Achillion Pharma, CTI BioPharma, Inovio Pharma, and Keryx Biopharma
February 10, 2016
category Publishing & Media
Achillion to Present at the Leerink Partners 5th Annual Global Healthcare Conference
February 08, 2016
Achillion Announces Appointments of Martha Manning as General Counsel and Amy Jennings as Head of Regulatory Affairs
February 03, 2016
from Dividend Channel
from Market News Video
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here